β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor‑β arrestin scaffold‑mediated activation of extracellular‑regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra‑neuraxial carcinoma